Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 1

Interventions

Specimen Handling 51 Carboplatin 49 pembrolizumab 45 Magnetic Resonance Spectroscopy 43 Pemetrexed 39 Cisplatin 34 Paclitaxel 24 durvalumab 23 osimertinib 20 Nivolumab 19 Gemcitabine 19 Radiosurgery 17 Docetaxel 17 atezolizumab 14 Taxes 12 Radiotherapy 12 Immunoglobulin G 12 Disulfides 12 130-nm albumin-bound paclitaxel 12 Etoposide 11 Educational Status 11 Biopsy 11 Radiation 10 Drug Therapy 10 Blood Specimen Collection 10 Platinum 9 Early Intervention, Educational 9 Cetuximab 9 Methods 8 Bevacizumab 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Lung Neoplasms × Transportation × 90 days × Clear all

NCT06628167 2026-03-24

LCS II

Abramson Cancer Center at Penn Medicine

Phase NA Completed

252 enrolled 7 charts

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡